Adjuvant Transarterial Chemoembolization With Sorafenib for Portal Vein Tumor Thrombus
Zhenwei Peng(Peking University), Ming Kuang(Sun Yat-sen University), Jiaping Li(Sun Yat-sen University), Jian Wu(Shanghai Medical College of Fudan University), Han Xiao(PLA Academy of Military Science), Jianfei Tu(Lishui Central Hospital), Wenzhe Fan(Chongqing Normal University), Zelong Liu(Harvard University), Yunpeng Hua(Sun Yat-sen University), Shaoqiang Li(State Key Laboratory of Respiratory Disease), Fuxi Huang(Panyu District Central Hospital), Shunli Shen(Sun Yat-sen University), Qiang He(Center for Excellence in Molecular Cell Science), Wenbo Guo(Sun Yat-sen University), Rong Tang(University of California Davis Medical Center), Dongming Li(Dalian University), Liangliang Qiao(Guangzhou University of Chinese Medicine), Wenquan Zhuang(Sun Yat-sen University), Wenxuan Xie(Sun Yat-sen University)
Cited by 15
Related Papers
Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis
|Journal of Medical Virology|2020|1.9k
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
|Nature Biotechnology|2010|918
Histone Lactylation Boosts Reparative Gene Activation Post–Myocardial Infarction
|Circulation Research|2022|532
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)
|Signal Transduction and Targeted Therapy|2023|295